Sign in

CIK 0001279704

  • Non-accelerated filer
  • Smaller reporting company

Cellectar Biosciences, Inc.

Sign in to watch
Ticker
CLRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043321804
Phone
+1 608-441-8120
Business address
100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
Former names
NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-01-25 Elefant Dov Chief Financial Officer Grant or award · Stock option (right to buy) +422,000 422,000
2021-03-04 Elefant Dov Chief Financial Officer Grant or award · Stock option (right to buy) +430,000 430,000
2020-12-28 Elefant Dov Chief Financial Officer Purchase +7,407 $1.35 $10K 11,755
2020-06-05 Elefant Dov Chief Financial Officer Purchase +4,348 $1.15 $5K 4,348
2020-06-05 Elefant Dov Chief Financial Officer Purchase · Series H Warrants +2,174 $0.01 $22 2,174
2020-02-03 Elefant Dov Chief Financial Officer Grant or award · Stock Option (right to buy) +10,000 10,000
2020-02-03 Elefant Dov Chief Financial Officer Grant or award +10,000 $2.71 $27K 10,000
2019-09-10 Elefant Dov Chief Financial Officer Grant or award · Stock Option (right to buy) +90,000 90,000

Page 1 of 1 · 8 trades